Canada's Ready for Psychedelic Therapy - CATALYST SUMMIT 2022

The Catalyst Summit 2022 reunited politicians, mycologists, doctors, psychotherapists and businesses for Canada’s premier 3rd annual conference dedicated to psychedelic medicine and its growing role in medicine, society and commerce.

Here are some highlights from some of the conference speakers and attendees, including:

– Jay Katz :Executive Director of the Canadian Psychedelic Association
– Bill Ciprick: CEO of Optimi Health
– David Harder – Co-CEO of ATMA Journey
– Najla Guthrie: President & CEO of KGK Science & CEO of Wellbeing Digital Sciences

Join our Newsletter (scroll to the bottom of the page and sign up):

Psychedelic Spotlight

#psychedelics #canada #mentalhealth

source

Sarah Abelsohn

The Revolution in Mental Health Care: Psychedelics | PSILERA

December 7, 2021June 2, 2024 Listen, Psychedelic Spotlight Videos

In today’s episode, we speak with the leaders of Psilera…

Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind

March 23, 2021June 2, 2024 Learn, Research

Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.

Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

August 20, 2021June 2, 2024 Learn, Research

“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital,” says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.